Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2006 1
2007 4
2008 3
2009 6
2010 1
2011 4
2012 4
2013 5
2014 1
2015 3
2016 1
2017 1
2019 1
2020 2
2021 1
2023 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial.
Ouédraogo A, Bougouma EC, Palacpac NMQ, Houard S, Nebie I, Sawadogo J, Berges GD, Soulama I, Diarra A, Hien D, Ouedraogo AZ, Konaté AT, Kouanda S, Myoui A, Ezoe S, Ishii KJ, Sato T, D'Alessio F, Leroy O, Tiono AB, Cousens S, Horii T, Sirima SB. Ouédraogo A, et al. Among authors: konate at. Front Immunol. 2023 Oct 16;14:1267372. doi: 10.3389/fimmu.2023.1267372. eCollection 2023. Front Immunol. 2023. PMID: 37908361 Free PMC article. Clinical Trial.
Integrated community case management: planning for sustainability in five African countries.
Yourkavitch J, Davis LM, Hobson R, Arscott-Mills S, Anson D, Baugh G, Sadruddin S, Mantshumba JC, Sambou B, Bakukulu JT, Leya PN, Luhanga M, Mgalula L, Jenda G, Nsona H, Nassivila SA, de Carvalho E, Smith M, Absi M, Aboubakar F, Konate AT, Wahab M, Ufere J, Isiguzo C, Ozor L, Gimba PB, Ndaliman I. Yourkavitch J, et al. Among authors: konate at. J Glob Health. 2019 Jun;9(1):010802. doi: 10.7189/jogh.09.010802. J Glob Health. 2019. PMID: 31275567 Free PMC article.
Admixture into and within sub-Saharan Africa.
Busby GB, Band G, Si Le Q, Jallow M, Bougama E, Mangano VD, Amenga-Etego LN, Enimil A, Apinjoh T, Ndila CM, Manjurano A, Nyirongo V, Doumba O, Rockett KA, Kwiatkowski DP, Spencer CC; Malaria Genomic Epidemiology Network. Busby GB, et al. Elife. 2016 Jun 21;5:e15266. doi: 10.7554/eLife.15266. Elife. 2016. PMID: 27324836 Free PMC article.
Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial.
Konaté AT, Yaro JB, Ouédraogo AZ, Diarra A, Gansané A, Soulama I, Kangoyé DT, Kaboré Y, Ouédraogo E, Ouédraogo A, Tiono AB, Ouédraogo IN, Chandramohan D, Cousens S, Milligan PJ, Sirima SB, Greenwood BM, Diallo DA. Konaté AT, et al. PLoS One. 2011;6(8):e23391. doi: 10.1371/journal.pone.0023391. Epub 2011 Aug 12. PLoS One. 2011. PMID: 21858097 Free PMC article. Clinical Trial.
Haemoglobin variants and Plasmodium falciparum malaria in children under five years of age living in a high and seasonal malaria transmission area of Burkina Faso.
Bougouma EC, Tiono AB, Ouédraogo A, Soulama I, Diarra A, Yaro JB, Ouédraogo E, Sanon S, Konaté AT, Nébié I, Watson NL, Sanza M, Dube TJ, Sirima SB. Bougouma EC, et al. Among authors: konate at. Malar J. 2012 May 4;11:154. doi: 10.1186/1475-2875-11-154. Malar J. 2012. PMID: 22559271 Free PMC article.
A phase 1b randomized, controlled, double-blinded dosage-escalation trial to evaluate the safety, reactogenicity and immunogenicity of an adenovirus type 35 based circumsporozoite malaria vaccine in Burkinabe healthy adults 18 to 45 years of age.
Ouédraogo A, Tiono AB, Kargougou D, Yaro JB, Ouédraogo E, Kaboré Y, Kangoye D, Bougouma EC, Gansane A, Henri N, Diarra A, Sanon S, Soulama I, Konate AT, Watson NL, Brown V, Hendriks J, Pau MG, Versteege I, Wiesken E, Sadoff J, Nebie I, Sirima SB. Ouédraogo A, et al. Among authors: konate at. PLoS One. 2013 Nov 11;8(11):e78679. doi: 10.1371/journal.pone.0078679. eCollection 2013. PLoS One. 2013. PMID: 24244339 Free PMC article. Clinical Trial.
Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthetic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa.
Sirima SB, Nébié I, Ouédraogo A, Tiono AB, Konaté AT, Gansané A, Dermé AI, Diarra A, Ouédraogo A, Soulama I, Cuzzin-Ouattara N, Cousens S, Leroy O. Sirima SB, et al. Among authors: konate at. Vaccine. 2007 Mar 30;25(14):2723-32. doi: 10.1016/j.vaccine.2006.05.090. Epub 2006 Jun 16. Vaccine. 2007. PMID: 17280744 Clinical Trial.
38 results